Current management of bipolar affective disorder: Is it reflective of the BAP guidelines?

Journal of Psychopharmacology

Volumn 20, Issue 1, 2006, Pages 128-131

  Farrelly, N ^a   Dibben, C ^b   Hunt, N ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FULBOURN HOSPITAL   (United Kingdom)

Author keywords

Bipolar disorder; Clinical practice; Depression; Evidence based guidelines; Mania

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; TRANQUILIZER; TRIAZINE DERIVATIVE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG ERUPTION; EDEMA; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; HYPOTHYROIDISM; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MANIA; MIXED MANIA AND DEPRESSION; MOOD DISORDER; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIST; SEDATION; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN; ADOLESCENT; EPIDEMIOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; GREAT BRITAIN; GUIDELINES; HEALTH CARE SURVEYS; HUMANS; LITHIUM; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEROTONIN UPTAKE INHIBITORS; TRIAZINES;

EID: 33645235167     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105056999     Document Type: Article

References (13)

1. Amsterdam J D, Brunswick D J (2003) Antidepressant monotherapy for bipolar type II major depression. Bipolar disorders 5: 388-395
2. Bowers Jr M B, McKay B G, Mazure C M (2003) Discontinuation of antidepressants in newly admitted psychotic patients. Journal of Neuropsychiatry and Clinical Neurosciences 15: 227-230
3. Colom F, Vieta E (2002) Non-adherence in psychiatric disorders: Misbehaviour or clinical feature? Acta Psychiatrica Scandinavica 105: 161-163
4. Colom F, Vieta E, Reinares, M, Martinez-Aran A, Torrent C, Goikolea J M, Gasto C (2003) Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. Journal of Clinical Psychiatry 64: 1101-1105
5. Goodwin F K (2002) Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. Journal of Clinical Psychiatry 63(Suppl. 10): 5-12
6. Goodwin F K, Fireman B, Simon G E, Hunkeler E M, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of the American Medical Association 290: 1467-1473
7. Keck Jr P E, McElroy S L, Strakowski S M, Bourne M L, West S A (1997) Compliance with maintenance treatment in bipolar disorder. Psychopharmacology Bulletin 33: 87-91
8. Lingam R, Scott J (2002) Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica 105: 164-172
9. Lloyd A J, Harrison C L, Ferrier I N, Young A H (2003) The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better. Journal of Psychopharmacology 17: 230-233
10. Moller H J, Bottlender R, Grunze H, Strauss A, Wittmann J (2001) Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? Journal of Affective Disorders 67: 141-146
11. Montgomery S A, Schatzberg A F, Guelfi J D, Kasper S, Nemeroff C, Swann A, Zajecka J (2000) Pharmacotherapy of depression and mixed states in bipolar disorder. Journal of Affective Disorders 59(Suppl. 1): S39-S56
12. Prien R F, Caffey Jr E M, Klett C J (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry 28: 337-341
13. Sachs G S, Printz D J, Kahn D A, Carpenter D, Docherty J P (2000) The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgraduate Medicine Spec No.: 1-104